Primacy of Resistance Rather Than Toxicity in Determining Outcome of Therapy for AML
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference9 articles.
1. First in many study of CPX 35, a liposomal carrie containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia;Feldman;J Clin Oncol,2011
2. Anti-CD45 radioimmunotherapy using (211) At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model;Orozco;Blood,2013
3. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment;Walter;J Clin Oncol,2011
4. Age and acute myeloid leukemia;Appelbaum;Blood,2006
5. The outcomes and costs of acute myeloid leukemia among the elderly;Menzin;Arch Intern Med,2002
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia;Mycoses;2021-12-16
2. Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells;Saudi Journal of Biological Sciences;2017-03
3. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy;International Journal of Cancer;2016-06-03
4. Synthesis of minoxidil conjugates and their evaluation as HL-60 differentiation agents;Bioorganic & Medicinal Chemistry Letters;2016-02
5. Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia;Journal of Clinical Medicine;2015-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3